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INTRODUCTION 
Infectious diseases are disorders caused 
by organisms such as bacteria, viruses, fungi 
or parasites. Many organisms live in our 
bodies and on our skin. They're normally 
harmless or even helpful, but under the certain 
conditions, some organisms may cause 
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ABSTRACT 
Background and aims: Infectious diseases are disorders caused by organisms such as 
bacteria, viruses, fungi or parasites .The Th9 subset develops in response to combined 
signals from TGF-b and IL-4 among a cacophony of other cytokines in an extracellular 
milieu. T helper 9 (Th9) cells,  as a novel CD4 T cell subset, seem to play a complex role 
in the outcome of specific immune responses. In this article, we aimed to review the role 
of these cells in infectious disease. 
Methods: In this mini-review study, we study 25 novel articles since 2009 to 2014 about 
the role of T helper 9 in some Infectious Diseases. 
Results: Pleural mesothelial cells promoted Th9 cell differentiation by presenting 
antigen. It significantly differentiated Th17, but not Th9 cells in the development of 
CVB3-induced VMC. The microenvironment of VMC seemed to contribute to the 
differentiation and proliferation of Th17 rather than to differentiation of Th9 cells. 
Having reviewed the limited number of articles considering this relevance, we came to 
this result that Lymphatic Filariasis and mycobacterium tuberculosis infections confirmed 
the existence of such relationship. In addition, Rapamycin resistant murine Th9 cells 
have a stable in vivo phenotype and inhibit graft-versus-host reactivity but concerning 
Viral Myocarditis, Th9 cells could not protect against it. 
Conclusion: The accurate molecular mechanisms underlying the generation and 
differentiation of human Th9 cells are not elucidated completely. Th9 cells exhibit  
Ag specific expansion in a chronic helminth infection (lymphatic filariasis), but in 
relevance to viral myocarditis, Th9 cells did not play an efficient role against it. 
However; knowing that whether Th9 cells participate in the protection against infections 
needs further research. 
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disease. Some infectious diseases can be 
passed from person to person. Some are 
transmitted by bites from insects or animals. 
Some others are acquired by ingesting 
contaminated food or water or being exposed 
to organisms in the environment. The 
specialized cytokine secretion profiles of  
T helper (TH) cells are the basis for a focused 
and efficient immune response.1 CD4+T 
helper subsets can differentiate various 
lineages in response to environmental cues 
such as cytokines or ligand interactions. Of the 
various lineages of T helper subsets, Th9 cells 
are a recent addition. Th9 cells develop from 
CD4 precursors in response to TGF-b and  
IL-4 and are primarily characterized by their 
increased secretion of IL-9.2 IL-9 is critical for 
defence against invasion by helminthes and it 
is conceivable that certain unique features that 
characterize this cytokine and the cells that 
produce it are related to this primordial 
function. While IL-9 producing CD4+T cells 
were previously classified as Th2 cells, recent 
studies have shown that Th9 cells are a 
distinct lineage of T helper cells, Th9 cells 
have been implicated in various disease 
processes that have been associated with Th2 
cells, including: helminthic infection, allergy 
and asthma.
2-8
 In this article, we aimed to 
review the role of these cells in infectious 
disease. Having reviewed the limited number 
of articles considering this relevance, we came 
to this result that Lymphatic Filariasis and 
mycobacterium tuberculosis infections 
confirmed the existence of such relationship. 
In addition, Rapamycin resistant murine Th9 
cells have a stable in-vivo phenotype and 
inhibit graft-versus-host reactivity but 
concerning Viral Myocarditis, Th9 cells could 
not protect against it. Further studies are, 
therefore warranted to determine the effect of 
the Th9 cells in infection. 
Naive CD4+T helper (Th) cells, after 
encountering specific antigen, become 
activated and differentiate into T helper 
subsets effectors, each characterized by a 
distinct pattern of cytokine secretion and 
function, including Th1, Th2 and Th17.
9
 
Recently, a new subset of CD4+T helper cells 
that predominantly secret cytokine interleukin-
9 (IL-9) is identified, termed Th9 cell.
10
 It has 
been reported to participate in tissue 
inflammation and immune-mediated diseases 
ranging from autoimmunity to asthma.
11
 
In this review, we propose to investigate 
the relationship between Th9 and different 
infections including viral, bacterial and fungi 
infections. At first, we review some 
mechanisms of differentiation and function of 
Th9, as well as their regulation, and then we 
go over some studies investigating the role of 
Th9 in some infectious disease. 
The Th9 subset develops in response to 
combined signals from TGF-b and IL-4 
among a cacophony of other cytokines in the 
extracellular milieu.12 The transcriptional 
network that regulates Th9 development 
includes TGFb-induced Sfpi1, and IL-4-
induced STAT6 that induces IRF4 as it 
represses Foxp3 and T-bet (Figure 1). 
 
 
 
Figure 1: Transcriptional network in Th9 cells 
 
Transcription factors including PU.1, 
downstream of TGF-β signals, and  
IL-4-activated STAT6 that promote 
expression of GATA3 and IRF4 contribute to 
the expression of the II9 gene in Th9 cells.
13
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Additional transcription factors, possibly 
downstream of them and additional cytokines, 
undoubtedly harmonize in efficient 
transcription of the Il9 gene.8 IL-9 promotes 
inflammation by stimulating growth of 
hematopoietic cells, particularly mast cells, 
and the secretion of factors including 
chemokines that recruit additional cells to 
inflamed sites.14 Th9 cells are capable of 
promoting autoimmune inflammation, 
although whether Th9 cells are required as a 
source of IL-9 for autoimmune inflammation 
is not still clearly established. Among the 
obstacles to defining these functions is the 
lack of a more detailed understanding of 
sensitization conditions that prime  
IL-9-producing T cells.15 More evidence 
supports the important role for Th9 cells in 
allergic inflammation, but how Th9 cells 
contribute to allergic disease, and how they 
cooperate with Th2 cells in promoting 
inflammation is the focus of ongoing 
investigations.16 
A study carried out by Zhi-Jian Ye and et 
al investigated the differentiation and 
recruitment of Th9 cells stimulated by pleural 
mesothelial cells in human mycobacterium 
tuberculosis infection. Their data showed that 
increased Th9 cells with the phenotype of 
effector memory cells were found to be 
intuberculous pleural effusion as compared 
with blood.17 Majority of these pleural Th9 
cells displayed the phenotype of effector 
memory cells. TGF-b was essential for Th9 
cell differentiation from naive CD4+ T cells 
stimulated with PMA and ionomycin in vitro 
for 5 h, and more addition of IL 1b, IL-4 or 
IL-6 leads to augmented of Th9 cell 
differentiation.18 The findings of this study 
also showed that the numbers of Th9 cells in 
TPE positively correlated with that of Th17 
cells, but not of Th1, Th2, or Tregs. It is 
supposed that IL-9 together with TGF-b 
promoted Th17 differentiation from naive 
CD4+T cells might account for this 
correlation.19 Tuberculous pleural effusion and 
supernatants of cultured pleural mesothelial 
cells were chemotactic for Th9 cells.20,21 IL-9 
significantly improved PMC wound healing 
and long term restoring and inhibited  
IFN-c-induced PMC apoptosis.22 
Moreover, in their study, pleural 
mesothelial cells promoted Th9 cell 
differentiation by presenting antigen. 
Collectively, these data provide new 
information concerning Th9 cells, in particular 
the collaborative immune regulation between 
Th9 cells and pleural mesothelial cells in 
human M. tuberculosis infection.  
In particular, pleural mesothelial cells 
were able to function as antigen-presenting 
cells to stimulate Th9 cell differentiation.17 
In another study with the subject of 
distinct different expression of Th17 and 
Th9cells in coxsackie virus B3-induced mice 
viral myocarditis (VMC), Kong Qing et al. 
have reported that it significantly 
differentiated Th17, but not Th9 cells elevated 
in the development of CVB3-induced VMC. 
The microenvironment of VMC seemed to 
contribute to the differentiation and 
proliferation of Th17 rather to differentiation 
of Th9 cells. Their preliminary data implied 
that Th9 cells could neither protect against 
VMC nor promote the disease because no 
change of Th9 cells had been observed in 
VMC.23 
Some research studies have initiated an 
evaluation of the in vitro phenotype and in 
vivo stability of rapamycin resistant Th9 cells 
during graft-versus-host-reactivity.24 
However, it is not known that whether Th9 
differentiation occurs in the presence of 
rapamycin or adoptively transferred donor 
Th9 cells would augment or restrict allo 
reactivity after experimental bone marrow 
transplantation.25 
They found that CD4+ T cells that were 
co-stimulated and polarized with TGF-b and 
IL-4 in the presence or absence of rapamycin 
each yielded effector cells of Th9 phenotype 
that secreted increased IL-9 and expressed a 
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transcription factor profile characteristic of 
both Th9 and Th2 cells (high GATA-3/low  
T-bet).24 Augmentation of T cell replete 
allografts with manufactured rapamycin 
resistant Th9 cells markedly reduced both 
CD4+ and CD8+ T cell engraftment and 
strongly inhibited allo-specific T cell secretion 
of IFN-c.26 The potency of Th9 cell inhibition 
of alloreactivity was similar to that of 
rapamycin resistant Th2 cells. Importantly, 
rapamycin resistant Th9 cells persisted and 
maintained their cytokine phenotype, thereby 
indicating limited differentiation plasticity of 
the Th9 subset.27 
As such, Th9 differentiation proceeds in 
the presence of rapamycin to generate a cell 
therapy product that maintains high  
IL-9 expression in vivo while inhibiting IFN-c 
driven alloreactivity.24 
A study was carried out about the 
association between IL-4-, TGF-β-, and IL-1-
dependent expansion of parasite antigen-
specific Th9 cells and clinical pathology in 
human lymphatic filariasis. 
This study demonstrates that these Th9 
cells exhibit Ag-specific expansion in a 
chronic helminth infection (lymphatic 
filariasis). Comparison of Th9 responses 
reveals that individuals with pathology 
associated with filarial infection exhibit 
significantly expanded frequencies of filarial 
Ag-induced Th9 cells, but not of IL9+ Th2 
cells in comparison with filarial-infected 
individuals without associated disease.28 
Moreover, the per cell production of IL-9 is 
significantly higher in Th9 cells compared 
with IL9+ Th2 cells, indicating that the  
Th9 cells are the predominant CD4+ T cell 
subset producing IL-9 in the context of 
human infection.29 This expansion was 
reflected in elevated Ag-stimulated  
IL-9 cytokine levels in whole blood culture 
supernatants.30 Finally, the frequencies of 
Th9 cells correlated positively with the 
severity of lymphedema (and presumed 
inflammation) in filarial-diseased 
individuals.31 This expansion of Th9 cells was 
dependent on IL-4, TGF-β, and IL-1 in vitro. 
They have therefore identified an important 
human CD4+ T cell subpopulation coex 
pressing IL-9 and IL-10, but not IL-4, the 
expansion of which is associated with disease 
in chronic lymphatic filariasis and could 
potentially have an important role in the 
pathogenesis of other inflammatory disorder.28  
 
CONCLUSION 
Th9 cells are a new subset of T helper 
cells, and the signature cytokine for Th9 cells 
is IL-9. Both Th9 cells and Th9 products are 
implicated in multiple disease settings. There 
are different molecular pathways identified 
thus far in the induction of Th9 cells, and 
activation of such diverse pathways requires 
integration of signals from TGF-β and IL-4 
cytokine receptors as well as costimulatory 
molecules. These signals converge on the 
induction of multiple transcription factors that 
collectively drive the development of Th9 
cells. However, the accurate molecular 
mechanisms underlying the generation and 
differentiation of human Th9 cells are not 
elucidated completely. Th9 cells have been 
shown to be important in allergy, 
autoimmunity, and antitumor responses. 
However, their role in human infectious 
diseases has not been explored in detail. 
Although some studies have demonstrated that 
Th9 might elicit inflammation 
13
 and 
contribute to the development of allergic 
diseases.
14,15
 For example, the numbers of Th9 
cells with the phenotype of effector memory 
cells in TPE (tuberculous pleural Effusion) 
were significantly increased when compared 
to their compartments in blood. Some studies 
indicated that the Th9 cells are the 
predominant CD4+ T cell subset producing 
IL-9 in the context of human infection. They 
significantly improved PMC wound healing 
and long term restoring and inhibited  
IFN-c-induced PMC apoptosis.32 Moreover, 
Th9 cells exhibit Ag-specific expansion in a 
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chronic helminth infection (lymphatic 
filariasis), but in relevance to viral 
myocarditis, Th9 cells did not show efficient 
role against it. Anyway, whether Th9 cells 
participate in the protection against infections 
warrants further research. For obtaining more 
concise results, it is suggested to study and 
compare more articles in this field and 
compare the signals pathway of Th9 in various 
infectious diseases. 
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